Versant Venture Capital VI, L.P. - 10%+ Owner at Monte Rosa Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
GLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Versant Venture Capital VI, L.P. since 8/26/2023

Holdings reported by Versant Venture Capital VI, L.P. for Monte Rosa Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.8M $129M $19.00 Jun 28, 2021 Direct
Common Stock 2.1M $39.9M $19.00 Jun 28, 2021 By Versant Vantage I, L.P.
Series A convertible preferred stock 0 Jun 28, 2021 Direct Common Stock
Series B convertible preferred stock 0 $2.00 Jun 28, 2021 By Versant Vantage I, L.P. Common Stock
Series B convertible preferred stock 0 $2.00 Jun 28, 2021 Direct Common Stock
Series C convertible preferred stock 0 $2.96 Jun 28, 2021 By Versant Vantage I, L.P. Common Stock

Transactions reported by Versant Venture Capital VI, L.P. for Monte Rosa Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.